Actively Recruiting
Proteinuria in Pre and Post Transplant
Led by University of Miami · Updated on 2025-11-21
100
Participants Needed
1
Research Sites
982 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients with focal segmental glomerulosclerosis (FSGS) who progress rapidly to end stage renal disease (ESRD) are at highest risk for development of recurrence of proteinuria following kidney transplantation. This study will look at serum specimens pre and post transplant, as well as kidney transplant specimens pre and post reperfusion to identify where the defects has occured that results in recurrence of proteinuria in a given kidney transplant.
CONDITIONS
Official Title
Proteinuria in Pre and Post Transplant
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Kidney transplant recipients
- Pediatric males and females up to the age of 25 years old
You will not qualify if you...
- Transplant recipients other than kidney
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Miami Miller School of Medicine Transplant Clinic
Miami, Florida, United States, 33136
Actively Recruiting
Research Team
G
George Burke, M.D.
CONTACT
L
Lissett Moni
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here